Repurpose T cell self-reactivity for #cancer #immunosurveillance . Check out our new study nature by brilliant Cancer Research Institute fellows Chun Chou and Xian Zhang with help from Chirag Krishna Josh Smith, MD, PhD, FACS and other Memorial Sloan Kettering Cancer Center colleagues. rdcu.be/cLLaG

An alternative surveillance system dlvr.it/SPhF5D

Nice concept. Eager to see whether this applies to other cancer types and mutations.

Ok, it is basically mRNA stability, not fancy ideas about codon usage and translation efficiency.

Finally found time to read the paper beyond quickly browsing through it. I'm afraid my disbelief has only increased. Apart from specific technical points, if a paper is questioning long and widely held beliefs that appear to be supported by lots of observations, one would 1/n

#dalle #dallemini This is a paradigm shifting AI tool to make illustration of scientific concept. These generated pictures look like real pseudo colored EM image.

Online Now: Innate-like T cells: A promising asset in anti-cancer immunity dlvr.it/SSf4Zj

When you are ready to switch fields for your Postdoc

Human microglia respond differently to amyloid than do mouse microglia. The former adopt antigen-presenting, cytokine-, and interferon-based responses, while the latter mainly assume the DAM phenotype. #alzheimersdisease KU Leuven Boston Children's ow.ly/eCBI50LnuVn

AlphaFold’s new rival? Meta AI predicts shape of 600 million proteins nature.com/articles/d4158…

Glad to share a holistic immuno-oncology perspective through the lens of #TGFb Nature Rev Immunol with implication for preclinical model choice for drug testing rdcu.be/cZJ5r

Glad to share a perspective on nutrient acquisition and metabolism control of macrophage responses in tumor Immunity with Cancer Research Institute fellows Xian Zhang Liangliang Ji authors.elsevier.com/a/1gOy23qNrUqG…

Check out this perspective on nutrient acquisition and metabolism control of macrophage responses in tumor, a collaboration between Xian Zhang Liangliang Ji & Ming Li Immunity #ASCO23 hubs.li/Q01RP-dM0

Reprogram tumor-associated macrophages to outmatch cancer cell competition. Excited to share our new study nature by brilliant Cancer Research Institute fellow Xian Zhang and collaborators! rdcu.be/dfA6f

Reprogram tumor-associated macrophages to outcompete endothelial progenitor cells and suppress tumor neoangiogenesis. Excited to share our new study Immunity by brilliant Mia Do , Wei Shi, and Cancer Research Institute fellow Liangliang Ji and collaborators!